Navigation Links
Emergency Services To Face The Axe

Patients are put to unnecessary risk due to shortage of staff at the accident and emergency units, doctors warn.//

The cutting down of staff in the casualty departments is a move to bail the NHS out of its monetary predicament, claims the British Association for Emergency Medicine (BAEM).

Last year, Bristol's South Mead Hospital was converted into a minor injuries unit and Kent and Canterbury Hospitals have stopped catering to trauma patients.

Martin Shalley, BAEM president said: "As well as leaving some patients miles from essential services, these plans are putting too much strain on nearby hospitals"

"The motive is to save money and that is not right. A&E is an easy target as it is relatively expensive and the running costs are hard to predict because you do not know how many patients need to be treated. If we keep stripping these services, we will put patients at risk."


'"/>




Page: 1

Related medicine news :

1. Gas Masks Dont Always Fit an Emergency
2. London Emergency Services Receive Wide Appreciation
3. WHO declares Tuberculosis – ‘An Emergency’ in Afrca
4. Indian Health Ministry approves sale of Emergency contraceptives as over the counter drug
5. Emergency Treatment Found Wanting In Anaphylactic Reactions
6. Chlamydia Screening To Be Offered With Emergency Contraception
7. Apollo And Stanford Team To Train Emergency Medical Technicians
8. Mumbai To Get Emergency Ambulance Service
9. Extravagant Pay For Emergency Department Head Of Caboolture Hospital
10. Andhra Junior Doctors Call Off Strike Partially; To Attend Emergency cases
11. Nursing Home Residents Receive Appropriate Emergency Care Despite Poor Funds
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Emergency Services Face The Axe

(Date:12/4/2009)..., , KANSAS CITY, Mo., Dec. 4 /PRNewswire/ ... by the National Association of Free Clinics (NAFC...just for the sick but also for anyone who is unins...cipants in the health clinic will receive preventi...the three previous large free clinic events this f...
(Date:12/4/2009)... Late recurrence is a risk for some pediatric canc... central nervous system, according to a new study ... National Cancer Institute . , This study was un... recurrence (after 5 years and up to 20 years) for...asker, M.D., of the Aflac Cancer Center and Blood ...
(Date:12/4/2009)... Rockville, MD "Why is it that men can be bastar...thor Lynn Hecht Schafran. The answer, according to... our interpretation of facial expressions. , In ...y the sex of a series of faces. In the first study...t lips (angry expressions) were more likely to be ...
(Date:12/4/2009)..., , BOSTON, Dec. 4 Substanti...n the healthcare community,s ability to diagnose a... progress in epilepsy management has not reached m...luding many of the nearly three million people in ...ording to Steven C. Schachter, M.D., president of ...
(Date:12/4/2009)...8 times more smoke inhaled through hookah, researc...ws) -- Water pipes are no safer than cigarettes fo...dy found that people who smoke tobacco with a wate...puts them at risk for heart disease and nicotine a...ged 18 to 50, who smoked tobacco using a water pip...
Breaking Medicine News(10 mins):Health News:Free Health Clinic Event Is Not Just for the Sick 2Health News:Are angry women more like men? 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4Health News:Water Pipes No Safer Than Cigarettes 2
...on diabetes drug although evidence is inconclusive...- The popular diabetes drug Avandia -- which has b...recently, heart attack -- will carry a revised "bl...ine, the maker of Avandia (rosiglitazone), a drug ...
..., Nov. 14 Panacea,Pharmaceuticals, Inc. announced...sed colon cancer diagnostic test, is now available...ple blood test that should facilitate,the identifi... Panacea Pharmaceuticals, is certified under the C...
...ption for Unwanted Babies, Prevents Abandonment an...nt of,Public Welfare Secretary Estelle B. Richman ...wborns that Pennsylvania,s safe haven law allows,t...y was found on the porch of a home in,Penbrook, Da...
...ceton scientists has discovered a key mechanism in...al breakthrough that could lead to treatments for ...anism is a chemical that cholera bacteria use for ...he chemical also can be used to disrupt the commun...
...at Leg Pain from Peripheral Arterial Disease is Ca...le are well,aware of the risk of cancer from smoki...ughout the body,s vascular system. Smoking damages...ic,aneurysm and subsequent death. This year for th...
... Innovative New Product Development in the Areas o...n Therapies, NEW YORK, Nov. 14 Nektar Therapeuti...ding Pulmonary and PEGylation,technology platforms...emphasizes our world-class talent and,innovative w...
Other Medicine News:Health News:Avandia Label to Get Heart-Attack Warning 2Health News:Avandia Label to Get Heart-Attack Warning 3Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 2Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 3Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 4Health News:Panacea Pharmaceuticals Announces the Availability of CC Detect(SM), a Serum-Based Diagnostic Test for Colon Cancer 5Health News:Pa. Department of Public Welfare Reminds New Parents About 'Safe Haven' Law 2Health News:Princeton scientists break cholera's lines of communication 2Health News:Princeton scientists break cholera's lines of communication 3Health News:A New Reason to Quit for the Great American Smokeout 2Health News:Nektar's Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York 2Health News:Nektar's Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York 3Health News:Nektar's Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York 4Health News:Nektar's Leading PEGylation and Pulmonary Technology Platforms Featured at R&D Day in New York 5
(Date:12/4/2009)...POLIS, Md., Dec. 4 Pharm...any developing medical countermeasures against bio... the Company is presenting results of a study demo...n inhalation anthrax model in the New Zealand Whit...ng an oral session at the HHS Public Health Emerge...
(Date:12/4/2009)... TARRYTOWN, N.Y., Dec. 4 Bayer Dia...inners of Bayer,s "Express Your Simple Win Creativ...elected the winning video entries submitted by chi...rand prize is an in-person meeting today with Nick...ke Nick, are: Caleb, age 6, from Danbury, CT, who ...
(Date:12/3/2009)...EW YORK, Dec. 3 Guidepoint Global...ounced the launch of their Sleep Apnea Tracker, a ...d projects trends and market share in the worldwid...er captures actual patient usage for 87 different ...from 15 different equipment providers going back t...
Breaking Medicine Technology:PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 2Bayer 'Express Your Simple Win Creativity Contest' Grand Prize Winners Announced 3Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Irvine Scientific and Selexis to Announce Results of Successful Collaboration 14427 1Irvine Scientific and Selexis to Announce Results of Successful Collaboration 14427 2Two of Arizona 26apos 3Bs Top Cosmetic Dentists Come Together at Scottsdale Smile Center 59275 1Two of Arizona 26apos 3Bs Top Cosmetic Dentists Come Together at Scottsdale Smile Center 59275 2Two of Arizona 26apos 3Bs Top Cosmetic Dentists Come Together at Scottsdale Smile Center 59275 3Industrial and Laboratory Equipment Distributor Tovatech LLC Launches Redesigned Interactive Website 59270 1Industrial and Laboratory Equipment Distributor Tovatech LLC Launches Redesigned Interactive Website 59270 2Industrial and Laboratory Equipment Distributor Tovatech LLC Launches Redesigned Interactive Website 59270 3
...ept. 2 Final results from,a 24-week study present...uggest that investigational olanzapine long-acting...nance of treatment benefit for up to six,months. A...LAI clinical,trials was also presented at the meet...ation that combines,Zyprexa(R) (olanzapine), an at...
...pt. 2 Data presented today,at the Annual Congress...,the investigational oral Factor Xa inhibitor DU-1...m (VTE) compared with dalteparin among patients,un...ry. There was a,statistically significant dose res...bleeding rates were low across the groups. DU-176b...
Other Medicine Technology:Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 2Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 3Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 4Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 5Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 6Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 7Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 8Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months 9Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b 2
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: